Literature DB >> 32621105

Gabapentin and memantine increases randomness of oscillatory waveform in ocular palatal tremor.

Wanchat Theeranaew1,2,3, Matthew J Thurtell4, Kenneth Loparo3, Aasef G Shaikh5,6,7,8.   

Abstract

Syndrome of oculopalatal tremor (OPT) causes pendular nystagmus of the eyes and its disabling consequence on the visual system. Classic pharmacotherapeutic studies revealed reduction in the eye velocity of the oscillatory waveforms. Subjective improvement in vision, however, remains out of proportionately low. Elegant models depicting quasi-sinusoidal coarse oscillations of the eyes highlighted two distinct oscillators; one at the inferior olive causing primary 2 Hz oscillations, while the second, independent oscillator, at the cerebellum adding the randomness to the waveform. Here we examined whether pharmacotherapy affects the randomness of the oscillatory waveform. Horizontal, vertical, and torsional angular eye positions were measured independently from both eyes as six subjects with OPT directed gaze toward a straight-ahead target. The measurements were performed before administration of alpha-2-delta calcium channel blocker (gabapentin) or NMDA receptor antagonist (memantine) and after the subjects were treated with each of these drugs for at least 8 days. Amplitude and velocity of eye oscillations were reduced by gabapentin and memantine, but there was an increase in the waveform randomness. We found that the increase in randomness was proportionate to the amount of reduction in the waveform velocity or amplitude. Hierarchical clustering revealed distinct patterns of oscillatory waveforms, with each subject belonging to a specific cluster group. The pharmacotherapy changed the waveform clustering pattern of the waveform in each subject. We conclude that in addition to incomplete resolution of the oscillation intensity, increased randomness could be one of the reasons why there is not enough clinical difference in the patients' visual quality.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain stem; Calcium channels; Cerebellum; Inferior olive; Purkinje neurons

Year:  2020        PMID: 32621105     DOI: 10.1007/s10827-020-00753-6

Source DB:  PubMed          Journal:  J Comput Neurosci        ISSN: 0929-5313            Impact factor:   1.621


  17 in total

1.  A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

Authors:  L Averbuch-Heller; R J Tusa; L Fuhry; K G Rottach; G L Ganser; W Heide; U Büttner; R J Leigh
Journal:  Ann Neurol       Date:  1997-06       Impact factor: 10.422

2.  Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings.

Authors:  M Goyal; E Versnick; P Tuite; J S Cyr; W Kucharczyk; W Montanera; R Willinsky; D Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

Review 3.  Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology.

Authors:  R J Leigh; L Averbuch-Heller; R L Tomsak; B F Remler; S S Yaniglos; L F Dell'Osso
Journal:  Ann Neurol       Date:  1994-08       Impact factor: 10.422

Review 4.  Acquired pendular nystagmus.

Authors:  Sarah Kang; Aasef G Shaikh
Journal:  J Neurol Sci       Date:  2017-01-10       Impact factor: 3.181

5.  Symptomatic and essential rhythmic palatal myoclonus.

Authors:  G Deuschl; G Mischke; E Schenck; J Schulte-Mönting; C H Lücking
Journal:  Brain       Date:  1990-12       Impact factor: 13.501

6.  Symptomatic and essential palatal tremor. 2. Differences of palatal movements.

Authors:  G Deuschl; C Toro; M Hallett
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

7.  Inferior olive hypertrophy and cerebellar learning are both needed to explain ocular oscillations in oculopalatal tremor.

Authors:  Simon Hong; R John Leigh; David S Zee; Lance M Optican
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

8.  Protective effect of gabapentin on N-methyl-D-aspartate-induced excitotoxicity in rat hippocampal CA1 neurons.

Authors:  Young-Sick Kim; Hyun-Kyung Chang; Jin-Woo Lee; Yun-Hee Sung; Sung-Eun Kim; Mal-Soon Shin; Jae-Woo Yi; Je-Hoon Park; Hong Kim; Chang-Ju Kim
Journal:  J Pharmacol Sci       Date:  2009-01       Impact factor: 3.337

9.  MR-imaging of post-traumatic olivary hypertrophy.

Authors:  G Birbamer; F Gerstenbrand; F Aichner; W Buchberger; A Chemelli; J Langmayr; R Lo Presti; P Pollicino; P Bramanti
Journal:  Funct Neurol       Date:  1994 Jul-Aug

Review 10.  Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

Authors:  J Kornhuber; M Weller; K Schoppmeyer; P Riederer
Journal:  J Neural Transm Suppl       Date:  1994
View more
  1 in total

1.  A 6-month trial of memantine for nystagmus and associated phenomena in oculopalatal tremor.

Authors:  Ana Inês Martins; Ricardo Soares-Dos-Reis; André Jorge; Cristina Duque; Daniela Jardim Pereira; Carlos Fontes Ribeiro; João Sargento-Freitas; Anabela Matos; Luís Negrão; João Lemos
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.